Is pelabresib plus ruxolitinib the paradigm-shifting combo therapy for myelofibrosis? Presented ByDr Raajit Rampal, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 3, MANIFEST-2 ConferenceEHA 2024 TypePeer-reviewed article 12 August 2024 14:28